Wilson Disease: An Overview and Approach to Management
- PMID: 32279718
- DOI: 10.1016/j.ncl.2020.01.005
Wilson Disease: An Overview and Approach to Management
Abstract
Wilson's disease is one of the few preventable movement disorders in which there are therapies that modify disease progression. This disease is caused by copper overload caused by reduced copper excretion secondary to genetic mutations in the ATP7B gene. Copper overload can lead to a variety of clinical presentations, including neurologic symptoms, liver failure, and/or psychiatric manifestations. There is often a delay in diagnosis of Wilson disease, and awareness of the diagnosis and management is important because of the treatable nature of this condition. This article reviews the clinical presentation, epidemiology, genetics, pathophysiology, diagnosis, and management of Wilson disease.
Keywords: Chelation; Copper; Movement disorder; Wilson disease.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure C. Mulligan: none. J.M. Bronstein: site principal investigator of the phase 2 and 3 trials of tetrathiomolybdate in Wilson disease run by Alexion and has received funds only to complete these studies.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical